Showing results (1-10 of 4) with videos related to
Sort By:
Pageof 1
Molecular Cancer Therapeutics|August 6, 2011
Dual-fluorescence isogenic high-content screening for MUC16/CA125 selective agentsThapi D Rao, Nestor Rosales, David R SpriggsClinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2010
Successful eradication of established peritoneal ovarian tumors in SCID-Beige mice following adoptive transfer of T cells genetically targeted to the MUC16 antigenAlena A Chekmasova, Thapi D Rao, Yan Nikhamin, et al.Plos One|May 13, 2015
Expression of the Carboxy-Terminal Portion of MUC16/CA125 Induces Transformation and Tumor InvasionThapi D Rao, Huasong Tian, Xun Ma, et al.Molecular Cancer Therapeutics|April 12, 2022
Dual Fluorescence Isogenic Synthetic Lethal Kinase Screen and High-Content Secondary Screening for MUC16/CA125-Selective AgentsThapi D Rao, Mengyao Xu, Stephanie Eng, et al.Pageof 1